UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Colesevelam has no acute effect on postprandial GLP-1 levels but abolishes gallbladder refilling

European journal of endocrinology, 2024-03, Vol.190 (4), p.314-326

2024

Volltextzugriff (PDF)

Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells

Nature communications, 2015-07, Vol.6 (1), p.7629-7629, Article 7629

2015

Volltextzugriff (PDF)

Intestinal bile acid sequestration improves glucose control by stimulating hepatic miR-182-5p in type 2 diabetes

American journal of physiology: Gastrointestinal and liver physiology, 2018-11, Vol.315 (5), p.G810-G823

2018

Volltextzugriff (PDF)

Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion

Diabetes, obesity & metabolism, 2016-06, Vol.18 (6), p.571-580

2016

Volltextzugriff (PDF)

Colesevelam in the management of type 2 diabetes

Journal of the Pakistan Medical Association, 2020-05, Vol.70 (5), p.934-936

2020

Volltextzugriff (PDF)

Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario

Current topics in medicinal chemistry, 2016-08, Vol.16 (19), p.2189-2200

2016

Volltextzugriff (PDF)

The effect of colesevelam treatment on bile acid and lipid metabolism and glycemic control in healthy men

Physiological research, 2016-01, Vol.65 (6), p.995-1003

2016

Volltextzugriff (PDF)

Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus : Focus on Bile Acid Sequestrants

Clinical drug investigation, 2012-01, Vol.32 (1), p.1

2012

Volltextzugriff (PDF)

Management of type 2 diabetes: new and future developments in treatment

The Lancet (British edition), 2011-07, Vol.378 (9786), p.182-197

2011

Volltextzugriff (PDF)

Beyond intestinal soap--bile acids in metabolic control

Nature reviews. Endocrinology, 2014-08, Vol.10 (8), p.488-498

2014

Volltextzugriff (PDF)

Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea‐predominant irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2015-03, Vol.41 (5), p.438-448

2015

Volltextzugriff (PDF)

Review article: bile acid diarrhoea – pathogenesis, diagnosis and management

Alimentary pharmacology & therapeutics, 2016-04, Vol.43 (8), p.884-898

2016

Volltextzugriff (PDF)

Effectiveness and Tolerability of Colesevelam HCl for Accelerated Elimination of Teriflunomide in Healthy Participants

Journal of clinical pharmacology, 2017-06, Vol.57 (6), p.747-750

2017

Volltextzugriff (PDF)

Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice

American journal of physiology: Gastrointestinal and liver physiology, 2013-02, Vol.304 (4), p.G371-G380

2013

Volltextzugriff (PDF)

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence

Diabetes, obesity & metabolism, 2010-05, Vol.12 (5), p.384-392

2010

Volltextzugriff (PDF)

Results of the glucose-lowering effect of WelChol study (GLOWS): A randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes

Clinical therapeutics, 2007, Vol.29 (1), p.74-83

2007

Volltextzugriff (PDF)

Identification and validation of potential genotoxic impurities, 1,3‐dichloro‐2‐propanol, and 2,3‐dichloro‐1‐propanol, at subtle levels in a bile acid sequestrant, colesevelam hydrochloride, using hyphenated GC–MS technique

Biomedical chromatography, 2023-01, Vol.37 (1), p.e5528-n/a

2023

Volltextzugriff (PDF)

Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin

Diabetes research and clinical practice, 2014-06, Vol.104 (3), p.401-409

2014

Volltextzugriff (PDF)

Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor– and liver X receptorα–controlled metabolic pathways in mice

Hepatology (Baltimore, Md.), 2010-03, Vol.51 (3), p.806-816

2010

Volltextzugriff (PDF)

Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1

American journal of physiology: Gastrointestinal and liver physiology, 2010-03, Vol.298 (3), p.G419-G424

2010

Volltextzugriff (PDF)

Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model

Cancer chemotherapy and pharmacology, 2019-03, Vol.83 (3), p.531-543

2019

Volltextzugriff (PDF)

Colesevelam: a new and improved bile acid sequestrant?

Current pharmaceutical design, 2013, Vol.19 (17), p.3115-3123

2013

Volltextzugriff (PDF)

Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: A retrospective chart review and patient questionnaire

Clinical therapeutics, 2009-11, Vol.31 (11), p.2549-2558

2009

Volltextzugriff (PDF)

Colesevelam hydrochloride and lanthanum carbonate interfere with the absorption of levothyroxine

Thyroid (New York, N.Y.), 2009-01, Vol.19 (1), p.77-79

2009

Volltextzugriff (PDF)

Efficacy of Colesevelam on Lowering Glycemia and Lipids

Journal of cardiovascular pharmacology, 2012-02, Vol.59 (2), p.198-205

2012

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(103)

Sprache

Englisch
(102)
Dänisch
(1)

Erscheinungsjahr

n.n

Thema

Colesevelam Hydrochloride
(92)
Science & Technology
(92)
Allylamine - Analogs & Derivatives
(90)
Humans
(90)
Life Sciences & Biomedicine
(90)
Allylamine - Therapeutic Use
(55)
Pharmacology & Pharmacy
(54)
Male
(50)
Allylamine - Pharmacology
(48)
Female
(44)
Anticholesteremic Agents - Therapeutic Use
(43)
Anticholesteremic Agents - Pharmacology
(37)
Cholesterol, Ldl - Blood
(35)
Adult
(34)
Biological And Medical Sciences
(34)
Allylamine - Adverse Effects
(33)
Medical Sciences
(33)
Colesevelam
(31)
Diabetes Mellitus, Type 2 - Drug Therapy
(31)
Middle Aged
(31)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Colesevelam has no acute effect on postprandial GLP-1 levels but abolishes gallbladder refilling

Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells

Intestinal bile acid sequestration improves glucose control by stimulating hepatic miR-182-5p in type 2 diabetes

Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion

Colesevelam in the management of type 2 diabetes

Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario

The effect of colesevelam treatment on bile acid and lipid metabolism and glycemic control in healthy men

Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus : Focus on Bile Acid Sequestrants

Management of type 2 diabetes: new and future developments in treatment

Beyond intestinal soap--bile acids in metabolic control

Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea‐predominant irritable bowel syndrome

Review article: bile acid diarrhoea – pathogenesis, diagnosis and management

Effectiveness and Tolerability of Colesevelam HCl for Accelerated Elimination of Teriflunomide in Healthy Participants

Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence

Results of the glucose-lowering effect of WelChol study (GLOWS): A randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes

Identification and validation of potential genotoxic impurities, 1,3‐dichloro‐2‐propanol, and 2,3‐dichloro‐1‐propanol, at subtle levels in a bile acid sequestrant, colesevelam hydrochloride, using hyphenated GC–MS technique

Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin

Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor– and liver X receptorα–controlled metabolic pathways in mice

Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1

Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model

Colesevelam: a new and improved bile acid sequestrant?

Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: A retrospective chart review and patient questionnaire

Colesevelam hydrochloride and lanthanum carbonate interfere with the absorption of levothyroxine

Efficacy of Colesevelam on Lowering Glycemia and Lipids

Suchergebnisse filtern